Power Law company profile

Cartesian Therapeutics

Biotech & Life Sciences · Gaithersburg, United States · Founded 2016 · IPO 2023 Thoroughbred

Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune diseases - Cartesian

Valuation

$75M

Market cap · May/2026

Revenue

$2.8M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on Cartesian Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Schooner Capital

Global footprint

Where Cartesian Therapeutics has talent and traffic

AI talent share

1.1% of workforce is AI talent
(1 of 89 staff)

Core AI00%

Other AI11.12%

Non-AI workforce8898.88%

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

4.2K monthly visits
across markets

🇺🇸 United States83.3%

🇮🇳 India16.7%

Top 2 markets shown

Market sentiment

What the market is saying about Cartesian Therapeutics

An AI-synthesized read of the highest-engagement posts about Cartesian Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cartesian Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles